|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: DURA PHARMACEUTICALS INC, 10-Q, EX-11, 2000-11-14 |
Next: CORVAS INTERNATIONAL INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED BALANCE SHEET AS OF SEPTEMBER 30, 2000, AND THE RELATED
CONSOLIDATED STATEMENT OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30,
2000, AND THE NOTES THERETO, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH CONSOLIDATED FINANCIAL STATEMENTS AND NOTES.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 80,332
<SECURITIES> 169,914
<RECEIVABLES> 32,702
<ALLOWANCES> 0
<INVENTORY> 18,082
<CURRENT-ASSETS> 305,315
<PP&E> 83,413
<DEPRECIATION> 0
<TOTAL-ASSETS> 861,914
<CURRENT-LIABILITIES> 105,721
<BONDS> 287,500
0
0
<COMMON> 46
<OTHER-SE> 398,950
<TOTAL-LIABILITY-AND-EQUITY> 861,914
<SALES> 186,207
<TOTAL-REVENUES> 237,437
<CGS> 39,615
<TOTAL-COSTS> 216,043
<OTHER-EXPENSES> 103,170
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 13,015
<INCOME-PRETAX> (76,401)
<INCOME-TAX> 400
<INCOME-CONTINUING> (76,801)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (76,801)
<EPS-BASIC> (1.73)
<EPS-DILUTED> (1.73)
</TABLE>
|
|